AhR Activation Reduces Colitis Symptoms in Mice
Author Information
Author(s): Singh Narendra P., Singh Udai P., Singh Balwan, Price Robert L., Nagarkatti Mitzi, Nagarkatti Prakash S.
Primary Institution: University of South Carolina School of Medicine
Hypothesis
Does activation of the aryl hydrocarbon receptor (AhR) influence Treg and Th17 differentiation during colitis?
Conclusion
AhR activation by TCDD promotes Treg differentiation and reduces Th17 cells, leading to decreased inflammation in colitis.
Supporting Evidence
- TCDD treatment reversed weight loss and inflammation in DSS-induced colitis.
- TCDD increased Treg numbers while decreasing Th17 cells in treated mice.
- Histological analysis showed reduced inflammation in TCDD-treated groups.
- Serum cytokine levels were significantly lower in TCDD-treated mice.
Takeaway
When mice with colitis were given a special chemical, it helped them feel better by changing how their immune cells worked.
Methodology
Mice were treated with DSS to induce colitis and then given TCDD to assess its effects on Treg and Th17 differentiation.
Potential Biases
Potential bias in interpreting results due to the specific mouse strains used.
Limitations
The study was conducted in a mouse model, which may not fully replicate human colitis.
Participant Demographics
C57BL/6 mice, aged 8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website